27
Participants
Start Date
March 31, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
April 30, 2009
KB001
Single-dose, 3mg/kg or 10mg/kg dose administered intravenously
Placebo
Placebo single-dose administered intravenously
Children's Hospital of Pittsburgh, Pittsburgh
Johns Hopkins University, Baltimore
University of Alabama, Birmingham
Nationwide Children's Hospital, Columbus
Case Western Reserve University, Cleveland
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Minnesota, Minneapolis
St. Louis Children's Hospital, St Louis
University of Colorado, Aurora
University of Utah, Salt Lake City
Lucille Packard Children's Hospital at Stanford, Stanford
Lead Sponsor
Humanigen, Inc.
INDUSTRY